Mi-Yeoung Jo, PsyD, ABPP (CN)

  • MI-YEOUNG JO, PSYD, ABPP (CN)

Licensure:

  • California (May 2006): PSY 20814; active
  • New York (June 2001): 014787; active
  • New Jersey (June 2004): 4179; inactive

Board Certification:

Board Certified in Clinical Neuropsychology

  • American Board of Professional Psychology (ABPP)/American Board of Clinical
    Neuropsychology (ABCN); May 2007

Board Certified Subspecialist in Pediatric Neuropsychology

  • American Board of Professional Psychology (ABPP)/American Board of Clinical
  • Neuropsychology (ABCN); December 2014

Education:

California School of Professional Psychology, Los Angeles, CA: APA accredited program

Doctor of Psychology (PsyD); May 1999
Master of Arts (MA); May 1997

Duke University, Durham, NC

Bachelor of Science (BS); May 1993
Bachelor of Arts (BS); May 1993

Professional Clinical Experience:

Independent Practice, Sherman Oaks, CA (Oct. 2006- present)

  • Founder and President of Jo NeuroAssessment Center, Inc.
  • Neuropsychological and psychological evaluations for children, adolescents, and adults
  • Regional Center consultant; assessments provided for children and adults with developmental disabilities
  • Forensic/medico-legal evaluations (English; Korean)

Cedars-Sinai Medical Center, Los Angeles, CA (April 2008- May 2018)

  • Staff neuropsychologist, Dept. of Rehabilitation; Part-time
  • Comprehensive neuropsychological services provided for children, adolescents, and adults presenting with a wide range of neurological and psychiatric disorders

Columbia-Presbyterian Medical Center, New York, NY (Sept. 2005- Aug. 2006)

  • Assistant Clinical Professor of Medical Psychology, in Psychiatry; Full-time
  • Inpatient neuropsychological services provided for acute rehab, psychiatry, and other hospital units
  • Comprehensive outpatient neuropsychological services provided for children, adolescents, and adults presenting with a wide range of neurological and psychiatric disorders
  • Training and supervision of externs

State University of New York, Downstate Medical Center, Brooklyn, NY (Oct. 2002- Aug. 2005)

  • Assistant Professor of Neurology/Attending, Division of Behavioral Neurology; Alzheimer’s Disease and Memory Disorders Center; Full-time
  • Comprehensive neuropsychological services provided for inpatients and outpatients presenting with a wide range of neurological and psychiatric disorders
  • Additional clinical services conducting Wada testing for the Department of Neurosurgery
  • Co-investigator in research studies in mild cognitive impairment and dementia

Bergen Neuropsychology Group, Hackensack, NJ (Sept. 2002- Aug. 2006)

  • Private practice; part-time
  • Comprehensive neuropsychological services provided for children and adolescents

Post-Doctoral Fellowship:

Bergen Neuropsychology Group, Hackensack, NJ (Sept. 2000- Aug. 2002)

  • Private practice; part-time
  • Two year, full-time, APPCN (Association of Postdoctoral Programs in Clinical Neuropsychology)fellowship in Clinical Neuropsychology
  • Supervisors: Kenneth C. Kutner, Ph.D., ABPP & Wilfred Van Gorp, Ph.D., ABPP
  • Rotations through Columbia-Presbyterian Medical Center (2001-2002) and Weill Medical College of Cornell University (2000-2001)
  • Clinical activities: Comprehensive neuropsychological evaluations of children, adolescents, and adults presenting with a wide variety of neurological

Children’s Hospital of Philadelphia, Philadelphia, PA (Sept. 1999- Aug. 2000)

  • One year, full-time, research and clinical adult postdoctoral fellowship
  • Supervisor: Carol L. Armstrong, Ph.D., ABN
  • Research activities: Investigated the neurocognitive phases of radiation effects and the cognitive causes of the identified memory deficits, worked with the neuro-radiologist to rate the gray and white matter of serial MRI scans for each patient, participated in the studies of the early-delayed and late delayed effects of radiotherapy in groups of patients with different histologic tumor types, and developed independent studies
  • Clinical activities: Comprehensive neuropsychological evaluations of adult brain tumor patients from the Hospital of the University of Pennsylvania (HUP)

Publications:

Jo, M. Ependymoma; Ewing’s sarcoma; Germ cell tumors; Gliomatosis cerebri; Meninges type tumors; Meningioma; Neurocytoma; Neuroma; Oligodendroglioma, Pineal tumors; Pituitary adenoma; Xanthroastrocytoma. In J. Kreutzer, B. Caplan, J. DeLuca (Eds), Encyclopedia of Clinical
Neuropsychology. New York: Springer. 2011.

JJo, M. & Dawson, L. (2010). Neuropsychological Assessment of Korean Americans. In D. Fujii (Ed.), Neuropsychology of Asian Americans (pp. 131-147). New York: Psychology Press.

Bodis-Wollner, I. & Jo, M. (2006). Getting around and communicating with the environment: Visual cognition and language in Parkinson’s disease. Journal of Neural Transmission, [Suppl] 70, 333-338.

Doniger, G.M., Crystal H., Jo, M-Y., & Simon, E.S. (2005). Computerized cognitive tests identify MCI in urban black individuals. Neurology, 64, A364..

Crystal, H., Jo, M., Morrison, D., Ganzer, A., Jacobs, A., & Desmond, D. (July 2004). Cognitive impairment in elderly urban black primary care patients. Neurobiology of Aging, Vol. 25, S123-S124.

Armstrong, C., Goldstein, B., Cohen, B., Jo, M., & Tallent, E. (2002). Clinical predictors of depression in patients with low-grade brain tumors: Consideration of a neurologic versus
psychogenic model. Journal of Clinical Psychology in Medical Settings, 9(2), 97-107.

Armstrong, C.L., Hunter, J.V., Ledakis, G.E., Cohen, B., Tallent, E.M., Goldstein, B.H., Tochner, Z., Lustig, R., Judy, K.D., Pruitt, A., Mollman, J.E., Stanczak, E.M., Jo, M., Than, T.L., & Phillips, P. (2002). Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings. Neurology, 59, 40-48.

Jo M.Y., Armstrong C.L., & Hunter J.V. (2000). Neuropsychological deficits in patients with meningiomas. Archives of Clinical Neuropsychology, 15:718-719.

Armstrong, C.L., Faison, D., Goldstein, B., Jo, M., Cohen, B. (2000). Longitudinal patterns of depression in patients with brain tumors. Archives of Clinical Neuropsychology, 15, 694.

Posters & Presentations:

Asher, A., Van Dyk, K., Bailey, C., Ganz, P., & Jo, M. (2016). Improved Cancer-Related Cognitive Dysfunction Up to One Year After Comprehensive Psycho-Educational Intervention, Emerging from the HazeTM. Presented at the International Cognition and Cancer Taskforce Biennial Meeting.

Asher, A., Bailey, C., & Jo, M. (2016). Emerging from the HazeTM: A Psycho-educational Series to Combat Subjective Cognitive Complaints after Cancer Treatment. Poster presented at the ASCO Cancer Survivorship Symposium on Jan. 16, 2016.

Asher, A., Jo, M., & Cowan, B. (2012). Emerging from the HazeTM: A Psycho-educational Series to Combat “Chemobrain.” Poster presented at the Association of Oncology Social Work, on May 31, 2012. (Awarded first prize for this abstract).

Doniger, G.M, Crystal, H., Jo, M., & Simon, E.S. (April 2005). Computerized cognitive tests identify MCI in urban black individuals. Poster presented at the 57th Annual Meeting of the American Academy of Neurology, Miami Beach, FL.

Crystal, H., Jo, M., Morrison, D., Ganzer, A., Jacobs, A., & Desmond, D. (July 2004). Cognitive impairment in elderly urban black primary care patients. Poster presented at the Alzheimer’s Association National Alzheimer’s Disease Education Conference, Philadelphia, PA.

Jo, M., Armstrong, C., & Hunter, J. Neuropsychological sequelae of meningiomas. (May 2000). Talk presented at Children’s Hospital of Philadelphia Neuropsychology Didactics, Philadelphia, PA.

Jo, M., Armstrong, C., & Hunter, J. Neuropsychological sequelae of meningiomas. (March 2000). Poster presented at the University of Pennsylvania Cancer Center Annual Scientific Symposium and Retreat, Philadelphia, PA.

Editorial Activities:

  • Ad hoc reviewer for the following journals: Archives of Clinical Neuropsychology, Child Neuropsychology, Journal of Clinical and Experimental Neuropsychology
  • Practice sample reviewer, American Academy of Clinical Neuropsychology (2007 – 2017)
  • Abstract reviewer, National Academy of Neuropsychology annual conference (2011- present)

Invited Lectures & Presentations:

“Coping with ‘Chemobrain’ after Cancer.” Tower Oncology Research Foundation, Beverly Hills, CA. July 11, 2013.“
“Chemobrain: Do I have it and what can I do about it?” Cancer Support Community, Santa Monica, CA. February 21, 2012.

Research Experience:

Cedars-Sinai Medical Center/UCLA joint research project.

  • Co-investigator; A Phase III Randomized Trial Evaluating Interventions to Improve Cognitive Function after Breast Cancer
  • 5% T/E provided for the project

S.U.N.Y Downstate Medical Center, Department of Neurology

  • Co-investigator; research studies in Mild Cognitive Impairment and dementia in an urban,
    multiethnic community

Children’s Hospital of Philadelphia, Department of Neurology

  • Contributing author; examined longitudinal, late-delayed effects of radiotherapy, using cognitive and neuroradiological outcomes. Paper accepted for publication (2002).
  • Contributing author; examined longitudinal patterns of depression in patients with brain tumors. Abstract accepted by the National Academy of Neuropsychology for their annual conference (Nov., 2000) and paper accepted for publication (2002).

Children’s Hospital Los Angeles, Mental Health Clinic/Leadership Education in Neurodevelopmental Disabilities Clinic

  • Principal investigator; examined the effects that viewing violence on television has on children’s anxiety levels using parent/guardian reports and the RCMAS (The Revised Children’s Manifest Anxiety Scale).

Professional Society Memberships:

  • American Board of Clinical Neuropsychology (ABCN)
  • American Board of Professional Psychology (ABPP)
  • International Neuropsychological Society (INS)
  • National Academy of Neuropsychology (NAN)

Foreign Languages Spoken:

Korean

References:

Available upon request

Arrowhead Evaluation Services
Please complete the following form and we will be in touch shortly. Arrowhead is committed to providing timely, professional and well-documented medical evaluation needs for QME, IME and AME in California.